Novo Nordisk has launched a competitive bid to acquire Metsera, a biotech company specializing in obesity treatment, aiming to surpass an offer from Pfizer. The bidding war signals increased interest and competition in the obesity-focused biotech sector.
Today's Morning Rounds brings you the latest health news, including a groundbreaking study revealing how the immune system evolves as we grow older.
Eli Lilly has formed a partnership with NVIDIA to create what is claimed to be the most powerful supercomputer owned and operated by a pharmaceutical company. This collaboration aims to leverage advanced AI technology to enhance pharmaceutical research and development capabilities.
UnitedHealth has announced a strategic shift to hire more of its doctors directly, aiming to enhance overall financial outcomes and operational control.
Intellia Therapeutics has announced a pause in two of its advanced CRISPR gene-editing clinical trials after a patient involved in one trial experienced liver damage that required hospitalization.
Explore the latest trends and developments from nearly three decades of IVF treatments in the United Kingdom. Also, catch up on other important health updates featured in the Morning Rounds newsletter.
Intellia Therapeutics is confronting a major survival challenge after its CRISPR gene-editing treatment was linked to severe, potentially fatal liver toxicity, raising serious safety concerns.
Researchers express concern that decisions about Medicaid home care eligibility often lack public transparency and may prioritize cost over actual health needs. Eligibility algorithms differ significantly across states, leading to inconsistent access to care.
Experts clarify how specific study designs can distinguish true cause-and-effect relationships from mere correlations.
The premier European oncological association has published its inaugural guidelines on the appropriate usage of large language models by its members in clinical settings.